Esperion’s Market Expansion and Positive Sales Outlook Merit a Buy Rating
at www.tipranks.com (Tue, 26-Mar 6:15 AM)
at www.benzinga.com (Mon, 25-Mar 2:44 PM)
Buy Rating Affirmed for Esperion on Growth Potential Post-FDA Approval
at www.tipranks.com (Mon, 25-Mar 1:05 PM)
Esperion stock jumps 18% in wake of FDA label expansions
at seekingalpha.com (Mon, 25-Mar 11:50 AM)
at www.tipranks.com (Mon, 25-Mar 9:25 AM)
Why Is Heart Disease-Focused Esperion Therapeutics Stock Trading Higher On Monday?
at www.benzinga.com (Mon, 25-Mar 9:24 AM)
Northland Securities Sticks to Their Hold Rating for Esperion (ESPR)
at www.tipranks.com (Mon, 25-Mar 8:55 AM)
Expanding Market Potential Justifies Buy Rating for Esperion Following FDA Approval
at www.tipranks.com (Mon, 25-Mar 6:46 AM)
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session
at www.benzinga.com (Mon, 25-Mar 5:34 AM)
Analysts Offer Insights on Healthcare Companies: Esperion (ESPR) and Masimo (MASI)
at www.tipranks.com (Mon, 25-Mar 5:30 AM)